- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07289633
Evaluering af postoperativ smerte efter brug af harpiksbaserede og biokeramiske rootkanalfyldningsmaterialer i mandibulære molarer med asymptomatisk apikal periodontitis
Evaluering af effekten af harpiksbaserede og biokeramiske rodfyldningsmaterialer på postoperativ smerte i underkæbens kindtænder med asymptomatisk apikal periodontitis behandlet i ét besøg
The goal of this clinical trial is to compare two root canal sealers in adults who need root canal treatment of a lower back tooth (mandibular first or second molar) with a dead (necrotic) pulp and no pain before treatment. The main question it aims to answer is: Does the type of sealer used to fill the root canals affect pain after single-visit root canal treatment?
Researchers compared a calcium silicate-based sealer (BioRoot RCS) with an epoxy resin-based sealer (AH Plus).
Participants:
Received root canal treatment completed in a single visit, with canals filled using the cold lateral compaction technique and one of the two sealers, assigned at random Recorded their pain on a 100 mm visual analog scale at 6, 12, and 24 hours and on days 2, 3, 5, and 7 after treatment Recorded whether, when, and how much pain medication (ibuprofen) they took during the 7-day follow-up
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This single-center, parallel-group randomized controlled trial was conducted at the Department of Endodontics, Faculty of Dentistry, Atatürk University (Erzurum, Türkiye). Seventy patients with a mandibular first or second molar with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (periapical index score ≤ 3), without preoperative pain, were randomly allocated in a 1:1 ratio to the BioRoot RCS group or the AH Plus group (35 per group).
All treatments were performed in a single visit by one operator following a standardized protocol. Canals were shaped with the WaveOne Gold reciprocating system and irrigated with 2.5% sodium hypochlorite, followed by final irrigation with 17% EDTA, 2.5% sodium hypochlorite, and saline. Allocation was concealed in sequentially numbered, opaque, sealed envelopes opened immediately before obturation. In both groups, canals were obturated by cold lateral compaction, and the teeth were permanently restored in the same visit.
The primary outcome was postoperative pain intensity on a 100 mm visual analog scale at 6, 12, and 24 hours and on days 2, 3, 5, and 7. The secondary outcome was the proportion of participants who used rescue analgesics (ibuprofen 400 mg) during the 7-day follow-up.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
palandöken
-
Erzurum, palandöken, Tyrkiet (Türkiye), 25100
- Atatürk University Faculty of Dentistry
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Age 18-65 years
- American Society of Anesthesiologists (ASA) physical status I
- Mandibular first or second molar with complete root formation and no previous endodontic treatment
- Pulp necrosis (no response to cold and electric pulp tests), confirmed clinically by the absence of bleeding in the pulp chamber during access cavity preparation
- Normal apical tissues or asymptomatic apical periodontitis according to the American Association of Endodontists diagnostic terminology (periapical index score of 3 or less)
- No spontaneous pain and no tenderness to percussion or palpation before treatment
- No analgesic intake within the previous 72 hours and no antibiotic intake within the previous month
- Written informed consent
Exclusion Criteria:
- Systemic disease, immunodeficiency, or regular medication use
- Pregnancy
- Known allergy to the materials or drugs used in the study
- Symptomatic apical periodontitis, acute apical abscess, or chronic apical abscess
- Swelling or sinus tract
- Periodontal probing depth greater than 3 mm
- Root canal calcification, internal or external root resorption, or open apex
- Teeth requiring a post-and-core restoration
- Periapical index score greater than 3
- Bleeding in the pulp chamber during access cavity preparation (pulp necrosis not confirmed)
- Two canals in the distal root
- Treatment that could not be completed in a single visit or that required intracanal medication
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: BioRoot RCS Group
Single-visit root canal treatment of mandibular molars with pulp necrosis; canals obturated by cold lateral compaction using the calcium silicate-based sealer BioRoot RCS. |
Single-visit root canal treatment of mandibular first or second molars with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (PAI ≤ 3). Canals were shaped with the WaveOne Gold reciprocating system, irrigated with 2.5% NaOCl, and finally irrigated with 17% EDTA, 2.5% NaOCl, and saline. Canals were obturated by cold lateral compaction using gutta-percha cones and the calcium silicate-based sealer BioRoot RCS (Septodont). No intracanal medication was used. |
|
Aktiv komparator: AH Plus Group
Single-visit root canal treatment of mandibular molars with pulp necrosis; canals obturated by cold lateral compaction using the epoxy resin-based sealer AH Plus. |
Single-visit root canal treatment of mandibular first or second molars with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (PAI ≤ 3). Canals were shaped with the WaveOne Gold reciprocating system, irrigated with 2.5% NaOCl, and finally irrigated with 17% EDTA, 2.5% NaOCl, and saline. Canals were obturated by cold lateral compaction using gutta-percha cones and the epoxy resin-based sealer AH Plus (Dentsply DeTrey). No intracanal medication was used. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Postoperative pain intensity
Tidsramme: 6, 12, and 24 hours and 2, 3, 5, and 7 days after treatment
|
Postoperative pain intensity was self-recorded by participants on a 100 mm visual analog scale (VAS), where 0 mm indicates no pain and 100 mm indicates the worst imaginable pain. VAS scores were categorized as no pain (0-4 mm), mild (5-34 mm), moderate (35-64 mm), severe (65-85 mm), and very severe pain (86-100 mm), and the groups were compared at each time point. |
6, 12, and 24 hours and 2, 3, 5, and 7 days after treatment
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of participants using analgesics
Tidsramme: From the end of treatment to day 7 after treatment
|
Proportion of participants in each group who took rescue analgesic medication (ibuprofen 400 mg, taken only in case of severe pain) during the follow-up period, as self-recorded on the pain record form together with the time and dose of each intake. |
From the end of treatment to day 7 after treatment
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- B.30.2ATA.0.01.00/559
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .